Compare RZLT & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | SRI |
|---|---|---|
| Founded | 2010 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 161.7M |
| IPO Year | N/A | 1997 |
| Metric | RZLT | SRI |
|---|---|---|
| Price | $2.35 | $6.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $10.33 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 15.9M | 140.4K |
| Earning Date | 02-11-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $874,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $3.54 |
| 52 Week High | $11.46 | $9.10 |
| Indicator | RZLT | SRI |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 56.31 |
| Support Level | $1.87 | $5.77 |
| Resistance Level | $2.43 | $6.07 |
| Average True Range (ATR) | 0.29 | 0.23 |
| MACD | 0.21 | 0.04 |
| Stochastic Oscillator | 56.73 | 90.48 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.